Surface enhanced Raman scattering of extracellular vesicles for cancer diagnostics despite isolation dependent lipoprotein contamination.


Journal

Nanoscale
ISSN: 2040-3372
Titre abrégé: Nanoscale
Pays: England
ID NLM: 101525249

Informations de publication

Date de publication:
17 Sep 2021
Historique:
pubmed: 3 9 2021
medline: 21 9 2021
entrez: 2 9 2021
Statut: epublish

Résumé

Given the emerging diagnostic utility of extracellular vesicles (EVs), it is important to account for non-EV contaminants. Lipoprotein present in EV-enriched isolates may inflate particle counts and decrease sensitivity to biomarkers of interest, skewing chemical analyses and perpetuating downstream issues in labeling or functional analysis. Using label free surface enhanced Raman scattering (SERS), we confirm that three common EV isolation methods (differential ultracentrifugation, density gradient ultracentrifugation, and size exclusion chromatography) yield variable lipoprotein content. We demonstrate that a dual-isolation method is necessary to isolate EVs from the major classes of lipoprotein. However, combining SERS analysis with machine learning assisted classification, we show that the disease state is the main driver of distinction between EV samples, and largely unaffected by choice of isolation. Ultimately, this study describes a convenient SERS assay to retain accurate diagnostic information from clinical samples by overcoming differences in lipoprotein contamination according to isolation method.

Identifiants

pubmed: 34473170
doi: 10.1039/d1nr03334d
pmc: PMC8447870
doi:

Substances chimiques

Lipoproteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14760-14776

Subventions

Organisme : NCI NIH HHS
ID : K12 CA138464
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA093373
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA241666
Pays : United States

Références

Biochem Cell Biol. 2007 Dec;85(6):696-708
pubmed: 18059528
Front Immunol. 2019 Jan 15;9:3164
pubmed: 30697216
Front Physiol. 2018 Oct 23;9:1479
pubmed: 30405435
Molecules. 2020 Nov 09;25(21):
pubmed: 33182340
J Extracell Vesicles. 2014 Mar 25;3:
pubmed: 24678386
PLoS One. 2015 Dec 21;10(12):e0145686
pubmed: 26690353
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
J Extracell Vesicles. 2014 Aug 14;3:
pubmed: 25206958
J Extracell Vesicles. 2015 Jul 02;4:28239
pubmed: 26142461
J Clin Med. 2019 Aug 27;8(9):
pubmed: 31461884
J Extracell Vesicles. 2014 Jul 08;3:
pubmed: 25018865
J Proteome Res. 2011 Apr 1;10(4):1437-48
pubmed: 21210632
Small. 2016 Jun;12(24):3292-301
pubmed: 27171437
Analyst. 2013 Sep 21;138(18):5338-43
pubmed: 23875182
Analyst. 2013 Jul 21;138(14):3967-74
pubmed: 23529624
J Thromb Haemost. 2014 May;12(5):614-27
pubmed: 24618123
Adv Biosyst. 2017 May;1(5):
pubmed: 29911169
Nanomedicine. 2017 Aug;13(6):2061-2065
pubmed: 28365418
J Extracell Vesicles. 2014 Sep 08;3:
pubmed: 25279113
Proteome Sci. 2014 Nov 18;12(1):50
pubmed: 25469109
J Extracell Vesicles. 2015 Dec 07;4:28533
pubmed: 26649679
Am J Physiol Renal Physiol. 2014 Jun 1;306(11):F1251-9
pubmed: 24694589
Sci Rep. 2016 Nov 17;6:37246
pubmed: 27853258
Anal Chem. 2018 Oct 2;90(19):11290-11296
pubmed: 30157378
PLoS One. 2020 Jul 2;15(7):e0235214
pubmed: 32614841
Expert Rev Proteomics. 2016;13(4):395-409
pubmed: 26973172
Clin Cancer Res. 2016 Apr 1;22(7):1757-66
pubmed: 26603257
Stem Cell Investig. 2017 Dec 19;4:98
pubmed: 29359137
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):9155-61
pubmed: 27432966
J Extracell Vesicles. 2013 Dec 31;2:
pubmed: 24455109
J Extracell Vesicles. 2012 Apr 16;1:
pubmed: 24009879
Front Immunol. 2015 Jan 30;6:6
pubmed: 25688242
Analyst. 2010 May;135(5):1138-46
pubmed: 20419267
Anal Chem. 2017 Jun 20;89(12):6695-6701
pubmed: 28541032
Sci Rep. 2017 Aug 29;7(1):9820
pubmed: 28852131
J Extracell Vesicles. 2013 Jan 10;2:
pubmed: 24009896
Sci Rep. 2016 Sep 19;6:33641
pubmed: 27640641
J Extracell Vesicles. 2019 Jan 27;8(1):1568780
pubmed: 30728924
Drug Test Anal. 2021 May;13(5):944-952
pubmed: 32627419
Int J Mol Med. 2016 Nov;38(5):1359-1366
pubmed: 28025988
Anticancer Res. 2015 Dec;35(12):6379-90
pubmed: 26637847
J Biomed Opt. 2015 Apr;20(4):047002
pubmed: 25858595
Biosens Bioelectron. 2010 Jul 15;25(11):2414-9
pubmed: 20427174
Nanomedicine. 2011 Dec;7(6):780-8
pubmed: 21601655
J Biomed Opt. 2012 Mar;17(3):037003
pubmed: 22502575
Anal Chem. 2005 Sep 15;77(18):5870-6
pubmed: 16159116
ACS Omega. 2020 Jun 30;5(27):16701-16710
pubmed: 32685837
Inorg Chem. 2011 Sep 5;50(17):8106-11
pubmed: 21797229
J Am Chem Soc. 2008 Dec 24;130(51):17214-5
pubmed: 19053187
Nat Cell Biol. 2019 Jan;21(1):9-17
pubmed: 30602770
Cell Mol Life Sci. 2018 Aug;75(15):2873-2886
pubmed: 29441425
Biosens Bioelectron. 2011 Mar 15;26(7):3167-74
pubmed: 21227679
Biochem Biophys Res Commun. 2019 Sep 3;516(4):1159-1166
pubmed: 31284955
J Lipid Res. 1992 Jan;33(1):123-30
pubmed: 1552228
Anal Chem. 2003 Jul 15;75(14):3631-6
pubmed: 14570219
Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):455-466
pubmed: 28634412
ACS Sens. 2020 Sep 25;5(9):2820-2833
pubmed: 32935542
Biopolymers. 2000;57(4):249-56
pubmed: 10861389
Anal Bioanal Chem. 2018 Aug;410(20):5019-5031
pubmed: 29907950
J Extracell Vesicles. 2015 Jul 17;4:27031
pubmed: 26194179
Circ Res. 2017 Sep 29;121(8):920-922
pubmed: 28963190
Sci Rep. 2016 Apr 18;6:24316
pubmed: 27087061
Anal Bioanal Chem. 2009 May;394(1):85-94
pubmed: 19266187
Proteomics. 2019 Apr;19(8):e1800167
pubmed: 30793499
ACS Sens. 2018 Dec 28;3(12):2637-2643
pubmed: 30381940
Int J Mol Sci. 2016 Feb 06;17(2):173
pubmed: 26861304
Am J Physiol Renal Physiol. 2019 Nov 1;317(5):F1098-F1110
pubmed: 31390267

Auteurs

Hanna J Koster (HJ)

Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA. rcarney@ucdavis.edu.

Tatu Rojalin (T)

Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA. rcarney@ucdavis.edu.

Alyssa Powell (A)

Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA. rcarney@ucdavis.edu.

Dina Pham (D)

Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA. rcarney@ucdavis.edu.

Rachel R Mizenko (RR)

Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA. rcarney@ucdavis.edu.

Andrew C Birkeland (AC)

Department of Otolaryngology - Head and Neck Surgery, University of California, Davis, Sacramento, CA 95817, USA.

Randy P Carney (RP)

Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA. rcarney@ucdavis.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH